Clinical Trial Update: Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the addition of efaproxiral (RSR13) to whole-brain radiation therapy with oxygen in women with brain metastases from breast cancer; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• efaproxiral (RSR13) (efaproxiral)

Snippet

Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: Breast Cancer, Metastases | Phase 3 | Status: COMPLETED